It's Time For-Jdrf-San Bernardino-Prevent Diabetes
The 2010 United States Census reported that San Bernardino had a population of 209,924. The population density was 3,519.6 people per square mile (1,358.9/km²). The racial makeup of San Bernardino was 95,734 (45.6%) White (19.0% Non-Hispanic White), 31,582 (15.0%) African American, 2,822 (1.3%) Native American, 8,454 (4.0%) Asian, 839 (0.4%) Pacific Islander, 59,827 (28.5%) from other races, and 10,666 (5.1%) from two or more races. Hispanic or Latino of any race were 125,994 persons (60.0%) The city is proud to be a home for such places as Jade Cove, Elfin Forest Preserve, Pacific Dunes Ranch Riding Stables, Bob Jones City to Sea Bike Trail, Piedras Blancas, Point Buchon Trail, Moonstone Beach, Pismo State Beach, Bluff Trail, Lopez Lake Recreation Area, Pewter Plough Playhouse, Central Coast Aquarium, Montana de Oro State Park, William Randolph Hearst Memorial Beach, Fiscalini Ranch Preserve, San Simeon State Park, Sweet Springs Nature Preserve, Elephant Seal Rookery, Outback Trail Rides, Oceano Dunes State Vehicular Recreation Area, Los Osos Oaks State Reserve, Leffingwell Landing, Avila Hot Springs, Elm Street Dog Park, Pacific Adventure Tours. Health Care & Social Assistance sector comprises firms providing health care and social assistance for individuals. The sector includes both health care and social assistance because it is sometimes difficult to distinguish between the boundaries of these two activities. The industries in this sector are arranged on a continuum starting with providing medical care exclusively, continuing with those providing health care and social assistance and finally finishing with only social assistance. The services provided in this sector are delivered by trained health practitioners and social workers with requisite experience. JDRF is the only organization with a strategic research plan to end T1D. Our strategies include: Artificial Pancreas Systems Artificial pancreas systems will eliminate blood glucose testing and carb counting by totally automating insulin dosing, initially preventing dangerous low blood sugars and eventually ensuring ideal glucose control. Complications JDRF’s complications research is leading to therapies to treat and even reverse some of the debilitating, costly, and life-threatening complications caused by T1D. Encapsulation JDRF’s encapsulation research will restore insulin independence for 18 months to two years
by implanting newly created beta cells into a protective capsule, which eliminates the need for toxic immune suppression therapies. List of all video credits is located here http://broadcaster.beazil.net/public/credits/youtube/videos/41745 Living with T1D is a constant balancing act. People with T1D must regularly monitor their blood-sugar level, inject or continually infuse insulin through a pump, and carefully balance their insulin doses with eating and daily activities throughout the day and night. T1D is a serious and stressful disease to manage. Treatment options are improving all the time, and people with T1D are able to lead normal, productive and inspiring lives. JDRF is driving research to improve the technology people with T1D use to monitor blood-sugar levels and deliver the proper doses of insulin, as well as research that will ultimately deliver a cure. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
It is important to note the main points –
CONCEPTT,diabetes management,Managing a hypo,charity,preprandial blood glucose,undiagnosed type 2 diabetes,2-h plasma glucose value,Novolin N,T1D complications,DPP,Diabetes and Pregnancy,connect,Type 1,charity,dipeptidyl peptidase 4 inhibitors,diabetes diarrhea,transplantation insulin-secreting cells,turn Type One into Type Now,hyperglycemia,Blood Glucose Meters,blood glucose target range,Diabetes Care,Cure Diabetes,PIs,T1D Community,Cost of insulin,reality of T1D,Grassroots model,T1D patterns,Online Diabetes Support Team,Roche Diabetes Care,worldwide effort,sugar breakdown,Medtronic Minimed Insulin Pump Users,diabetic,donation,Understanding Type 1,Blood Glucose,using insulin,UKPDS Study,T1D Care Kit,ketosis,Veterans Affairs Diabetes Trial,insulin pump therapy,Promise to Remember Me,Artificial Pancreas,Action to Control Cardiovascular Risk in Diabetes Trial,Daily.